RheumaGen and SiVEC Biotechnologies Announce CGT Partnership and In Vivo Program to Cure Common Autoimmune Diseases

RheumaGen & SiVEC partner to co-develop scalable gene-editing therapies to cure autoimmune diseases using SiVEC’s BactPac™ platform.